MetLife Investment Advisors »

Blueprint Medicines shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.0M 32k 92.24
2023-09-30 $1.6M 32k 50.22
2023-06-30 $2.0M 32k 63.20
2023-03-31 $1.4M 32k 44.99
2022-12-31 $1.4M 32k 43.81
2022-09-30 $2.1M 32k 65.89
2022-06-30 $1.6M 32k 50.51
2022-03-31 $2.0M 32k 63.88
2021-12-31 $2.2M 21k 107.11
2021-09-30 $2.1M 21k 102.81
2021-06-30 $1.8M 21k 87.96
2021-03-31 $2.0M 21k 97.23
2020-12-31 $2.4M 22k 112.16
2020-09-30 $2.2M 24k 92.70
2020-06-30 $1.9M 24k 77.98
2020-03-31 $1.3M 23k 58.48
2019-12-31 $1.6M 21k 80.11
2019-09-30 $1.6M 22k 73.47
2019-06-30 $1.8M 19k 94.35
2019-03-31 $1.4M 18k 80.05
2018-12-31 $960k 18k 53.91
2018-09-30 $2.2M 28k 78.04
2018-06-30 $1.2M 19k 63.46
2018-03-31 $1.8M 19k 91.70
2017-12-31 $1.5M 19k 75.43